Fostering Innovation in Long-Lead-Time Investments—An Approach for Early-Stage Portfolio Decision Making
Free Webinar; See Registration Page for Dates and Times
April 27, 2021
Comparing investments with long lead-times can be an exercise in futility. Trying to obtain credible inputs for outcomes 15 to 20 years hence is fraught with challenges and conventional methodology, such as modeling net present value, is of limited effectiveness. As a result, portfolio decisions—in industries from genomics to technology to energy—often skew toward low-risk choices, effectively cutting off the innovative pipeline necessary to achieve corporate growth.
A more-effective approach has emerged that can guide decision making for early stage, long-term investments. In this webinar, we demonstrate an approach that starts with corporate objectives and combines multi-attribute utility theory and value-focused thinking to create new and better distinctions for decision making. By separating discussions of preferences and corporate objectives from the scientific evaluation of individual project opportunities, decision teams can better evaluate investments—even those that are decades away from results.
Using an example from the pharmaceutical industry, we will demonstrate the benefit of this approach for early-stage portfolio decisions.
Attend this webinar to learn:
- Why conventional assessment methods can’t properly account for long-lead-time projects.
- The challenges of obtaining credible inputs when potential outcomes are 20-plus years in the future.
- How leading companies are fostering innovation using multi-attribute utility theory combined with value-focused thinking.
THIS WEBINAR WILL BE OFFERED TWICE: April 27 at noon Eastern Daylight Time and April 28 at 11 a.m. Central European Summer Time
Deepak Veeraraghavan leads SDG’s global life science practice and strategy consulting practice in Europe. He leads client teams in strategy development, portfolio management, change management, and decision process design. Based in Düsseldorf, he has served clients in Asia, Europe, and North America.
Eric Bickel is professor and director of the graduate program in Operations Research & Industrial Engineering at The University of Texas at Austin. He is a partner and member of the board of Strategic Decisions Group. Dr. Bickel will moderate the April 27 session of this webinar.
Mark Seidler is chief executive officer of Strategic Decisions Group. He has more than 20 years of experience in structuring and development of strategies for global leaders in pharmaceuticals, agrosciences, and fine chemicals in Europe, the U.S., and Asia. Dr. Seidler will moderate the April 28 session of this webinar.